7Baggers
 Published on: 2025-10-02 21:54:56  newser.com Fri, 03 Oct 2025 02:54:56 GMT
 Anebulo Pharmaceuticals Advances Cannabis Toxicity Treatment  TipRanks Wed, 01 Oct 2025 06:55:29 GMT
 anebulo pharmaceuticals, inc. sec 10-k report  TradingView Mon, 29 Sep 2025 20:38:00 GMT
 published on: 2025-09-27 19:36:03  newser.com Sun, 28 Sep 2025 00:36:03 GMT
 Published on: 2025-09-27 17:42:17  newser.com Sat, 27 Sep 2025 22:42:17 GMT
 Anebulo begins phase 1 trial of IV cannabis toxicity treatment By Investing.com  Investing.com Nigeria Fri, 26 Sep 2025 10:24:44 GMT
 Anebulo begins Phase I trial of IV cannabis antidote  Clinical Trials Arena Fri, 26 Sep 2025 09:27:28 GMT
 Anebulo begins phase 1 trial of IV cannabis toxicity treatment  Investing.com Thu, 25 Sep 2025 12:11:30 GMT
 published on: 2025-09-24 05:39:09  newser.com Wed, 24 Sep 2025 10:39:09 GMT
 published on: 2025-09-23 19:22:34  newser.com Wed, 24 Sep 2025 00:22:34 GMT
 published on: 2025-09-22 09:37:16  newser.com Mon, 22 Sep 2025 14:37:16 GMT
 published on: 2025-09-22 06:33:49  newser.com Mon, 22 Sep 2025 11:33:49 GMT
 published on: 2025-09-19 14:00:51  newser.com Fri, 19 Sep 2025 19:00:51 GMT
 published on: 2025-09-15 00:29:12  newser.com Mon, 15 Sep 2025 05:29:12 GMT
 published on: 2025-09-14 13:13:00  newser.com Sun, 14 Sep 2025 18:13:00 GMT
 Anebulo Pharmaceuticals Explores Strategic Alternatives Update  TipRanks Fri, 12 Sep 2025 07:00:00 GMT
 published on: 2025-09-04 06:20:38  Newser Thu, 04 Sep 2025 11:20:38 GMT

Anebulo Pharmaceuticals Inc
(NASDAQ:ANEB) 

ANEB stock logo

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing solutions for people suffering from acute cannabinoid intoxication (ACI) and substance addiction.

Founded: 2020
Founder: Joseph F. Lawler 
CEO: Daniel Schneeberger  
Sector:
Industry:

Share this website to your friends